WROBJZIERWFGSO-VQTJNVASSA-N
C29H32F6N8O4 — CID 155635206
Data last refreshed: (MolForge compound catalog, from PubChem)
About WROBJZIERWFGSO-VQTJNVASSA-N
WROBJZIERWFGSO-VQTJNVASSA-N (PubChem CID 155635206) has the molecular formula C29H32F6N8O4 and a molecular weight of 670.62 g/mol. Its IUPAC name is [1-(trifluoromethyl)cyclopropyl]methyl (3R,4S)-3-[[5-[4-amino-5-[(4,4-difluoropiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]-2-methoxypyridine-3-carbonyl]amino]-4-fluoropyrrolidine-1-carboxylate.
Molecular Properties
| Compound Name | WROBJZIERWFGSO-VQTJNVASSA-N |
|---|---|
| PubChem CID | 155635206 |
| Molecular Formula | C29H32F6N8O4 |
| Molecular Weight | 670.62 g/mol |
| Exact Mass | 670.25 |
| IUPAC Name | [1-(trifluoromethyl)cyclopropyl]methyl (3R,4S)-3-[[5-[4-amino-5-[(4,4-difluoropiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]-2-methoxypyridine-3-carbonyl]amino]-4-fluoropyrrolidine-1-carboxylate |
| SMILES | COc1ncc(-c2cc(CN3CCC(F)(F)CC3)c3c(N)ncnn23)cc1C(=O)N[C@@H]1CN(C(=O)OCC2(C(F)(F)F)CC2)C[C@@H]1F |
| InChI | InChI=1S/C29H32F6N8O4/c1-46-25-18(24(44)40-20-13-42(12-19(20)30)26(45)47-14-27(2-3-27)29(33,34)35)8-16(10-37-25)21-9-17(22-23(36)38-15-39-43(21)22)11-41-6-4-28(31,32)5-7-41/h8-10,15,19-20H,2-7,11-14H2,1H3,(H,40,44)(H2,36,38,39)/t19-,20+/m0/s1 |
| InChIKey | WROBJZIERWFGSO-VQTJNVASSA-N |
| XLogP | 3.84 |
| TPSA | 140.21 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 670.62 |
| LogP ≤ 5 | 3.84 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155635206 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.